Discover 1,042 paid clinical trials in West Palm Beach, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,042
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
for
Acute Myeloid Leukemia,
Location: Pembroke Pines FL, Miami FL, Ruskin FL, Tampa FL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05564390
Phase 2, Recruiting
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
for
Asthma
Location: Pembroke Pines FL, Miami FL, Saint Cloud FL,
Sponsor: AstraZeneca
Sex: All
Age: 4 - 11
Code: NCT07525375
Phase 2, Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Location: Miami FL, Tampa FL, Chapel Hill NC, Durham NC,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT07294170
Recruiting
A Study of Buntanetap in Participants With PD
for
Parkinson's Disease (PD), Deep Brain Stimulation
Location: Aventura FL, Miami FL, Winter Park FL, Tampa FL,
Sponsor: Annovis Bio Inc.
Sex: All
Age: 40 - 70+
Code: NCT07284784
Phase 2, Phase 3, Recruiting
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod